Oral Cavity Cancer
📧 Sign up to get email alerts when something new happens for Oral Cavity Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer [Phase 2]
This Phase 2 clinical trial is evaluating BMX-001 as a radioprotector added to standard chemoradiation therapy for head and neck cancers and…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery [NA]
This study, sponsored by the University of Wisconsin, Madison, aims to identify biomarkers predicting response of oral cavity cancer to neoa…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population [Phase 2]
Phase 2 clinical trial evaluating methotrexate, erlotinib, and celecoxib for recurrent/metastatic oral cavity and lip cancers; currently rec…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Customized 3D Printed Oral Stents During Head and Neck Radiotherapy [Phase 2]
A Phase 2 clinical trial, sponsored by MD Anderson Cancer Center, is evaluating customized 3D-printed oral stents during head and neck radio…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers [NA]
This source reports on a clinical trial evaluating a dyadic yoga intervention for patients with head and neck cancer undergoing radiotherapy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial is testing adding chemotherapy or chemo-immunotherapy to standard surgery for advanced head and neck cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin [Phase 1]
Phase 1 trial evaluating the addition of M3814 (peposertib), a DNA-PK inhibitor, to radiation therapy in patients with advanced head and nec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating atezolizumab and/or bevacizumab with or without standard chemotherap…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study [Phase 2]
This document reports a Phase 2 clinical trial called HEADLIGHT evaluating intensity-modulated proton therapy or conventional X-ray therapy …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent Blue V and Indocyanine Green Dyes [Phase 2]
A Phase 2 prospective clinical study to identify secondary sentinel lymph nodes in patients with oral cavity cancer or head and neck cancer,…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer [Phase 1]
Phase 1 trial evaluating TMV vaccine therapy alone and with pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma; cu…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers [Phase 3]
A Phase 3 clinical trial evaluating flap-sparing approaches during postoperative radiotherapy for oral cavity cancer, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
This clinical trial update presents extended follow-up data from a Costa Rica study of an HPV-16/18 vaccine in young women. It compares vacc…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action
A clinical trial update describing an oncology study investigating the connections between undernutrition and sensorial changes (taste/smell…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) [Phase 2]
Phase 2 clinical trial evaluating sacituzumab govitecan in combination with cetuximab for head and neck squamous cell cancers is currently r…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC [Phase 2]
Phase 2 neoadjuvant chemoimmunotherapy trial for resectable head and neck squamous cell carcinoma using camrelizumab with paclitaxel and car…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating metformin hydrochloride in combination with doxycycline for head and neck squamous cell carcinoma has be…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer [Phase 1]
Phase 1 trial evaluating intratumoral delivery of saRNA particles expressing IL-12 for head and neck cancers is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Collagen Matrix in Oral Cancer Surgery
Clinical trial evaluating the use of a collagen matrix in oral cancer surgery has completed. The available snippet does not present trial re…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT [NA]
A clinical trial from Chang Gung Memorial Hospital studies circulating tumor cell counts in postoperative ENE-positive oral cavity cancer pa…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Enhancing Oral Cancer Awareness [NA]
A Virginia Commonwealth University-sponsored clinical trial aims to enhance oral cancer awareness using a chatbot for patient education and …
-
CLINICAL_TRIALS other · 2025-12-11Clinical Trial Update: Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy [NA]
This entry reports a multi-site clinical trial comparing navigation to treatment as usual to improve timely initiation of adjuvant therapy i…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors [NA]
The ENHANCE study is an active, not-recruiting trial assessing exercise and nutrition interventions for head and neck cancer survivors, incl…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Retreatment With Intratumoral Diffusing Alpha Radiation Emitters [NA]
A completed clinical trial evaluating retreatment with intratumoral diffusing alpha radiation emitters for skin cancer, oral cavity mucosal …
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors [Phase 4]
Phase 4 clinical trial uses serial MRI to predict radiation-induced changes in normal tissue for patients with malignant oral cavity neoplas…